	Exploring the influence of the bladder microbiome on BCG immunotherapy outcomes for high-risk non muscle invasive bladder cancer. Minerva Urol Nephrol Tulone G, Pavan N, Fasciana TM, Martorana A, Minasola C, Tricoli MR, Claps F, Mariyam L, Marmo D, Serra N, Giammanco A, Simonato A. PMID: 41410660 [PubMed - indexed for MEDLINE]
	Elevated creatinine-to-hemoglobin ratio is a novel preoperative marker for worsened survival outcomes in upper tract urothelial carcinoma: analysis from the ROBUUST registry. Minerva Urol Nephrol Meagher MF, Cerrato C, Nguyen MV, Autorino R, Mehrazin R, Eun D, Margulis V, Uzzo R, Porter J, Sundaram C, Abdollah F, Mottrie A, Minervini A, Antonelli A, Cerruto MA, Ferro M, Djaladat H, Wu Z, Ghoreifi A, Hakimi K, Saitta C, Saidian A, Walia A, Pandolfo SD, Tellini R, Veccia A, Mazzone E, Rha K, Gonzalgo M, Derweesh IH. PMID: 41410659 [PubMed - indexed for MEDLINE]
	Association between symptoms of acute cystitis and findings of bladder cancer in the Swedish standardized pathway for macroscopic haematuria. Scand J Urol Starlander G, Shkair R, Wagenius M, Bläckberg M. PMID: 41410294 [PubMed - indexed for MEDLINE]
	Validation of fibroblast activation protein and Î±-smooth muscle actin as prognostic biomarkers in prostate cancer through AI-assisted image analysis of dual-marker IHC. J Pathol Clin Res Säilä J, Lehto TP, Rannikko A, Kallioniemi O, Mirtti T, Pellinen T. PMID: 41410015 [PubMed - indexed for MEDLINE]
	Artificial Intelligence as a Tool in the Diagnosis of Bladder Cancer: A Narrative Review. Cureus Ishtiaq S, Farouk K. PMID: 41409960 [PubMed]
	Targeting PSMB5-induced PANoptosis in bladder cancer: multi-omics insights and TCM candidate discovery. Front Immunol Chang Z, Wang J, Cao J, Fan X, Li K, Wang C, Zhang Y, Wang L, Yang J, Chen S, Yang L. PMID: 41409300 [PubMed - indexed for MEDLINE]
	Optimizing prostate cancer SBRT: Acute GU toxicity outcomes of urethral delineation methods. J Radiosurg SBRT Sharma G, Banerjee S, Kataria T, Arunendu R, Gupta D, Bisht S, Narang K, Mayank M, Shishak S, Bhushan B, Abraham SK. PMID: 41409184 [PubMed]
	Prevalence and time trends of human papillomavirus in penile cancer over 26â€‰years-A comprehensive study of 1040 penile cancer cases from Denmark. Int J Cancer Stærk MG, Munk C, Stilling C, Elversang J, Kjær-Frifeldt S, Hjulskov SH, Stifter-Vretenar S, Schou MA, Aagaard M, Petersen PM, Jakobsen JK, Toft BG, Kjær SK. PMID: 41408670 [PubMed - as supplied by publisher]
	Efficacy and toxicity of low-doses versus standard-dose enzalutamide in advanced prostate cancer. a real-world study with implications for cancer prevention/interception. BMC Cancer Oliva M, Boitano M, Carbone A, Briata IM, Webber TB, Corradengo D, Introini C, Puntoni M, Ennas M, Germinale F, Provinciali N, Clavarezza M, Gozza A, Defferrari C, D'Amico M, Parnes HL, DeCensi A. PMID: 41408519 [PubMed - as supplied by publisher]
	Role of APOC1 and NOP16 in the diagnosis of prostate cancer. BMC Urol Yan Y, Shuang S, Fan Z, Wei Z, Li B, Yuan Q, Lu Y, Ye C, Lu P. PMID: 41408238 [PubMed - as supplied by publisher]
	Preclinical evaluation of (68)Ga- and (177)Lu-Labeled AP-01 for the targeted treatment of prostate cancer with moderate PSMA expression. Eur J Nucl Med Mol Imaging Liu Y, Wang X, Pan X, Huang X, He S, Zhang J, Xu X, Song S. PMID: 41407974 [PubMed - as supplied by publisher]
	A roadmap for future clinical research in advanced prostate cancer: Findings from the Advanced Prostate Cancer Consensus Conference (APCCC) 2024. Eur J Cancer Vogl UM, Merler S, Angrisani A, Turco F, Davis ID, Efstathiou JA, Fizazi K, James ND, Shore N, Small EJ, Smith MR, Sweeney CJ, Tombal B, Zilli T, Herrmann K, Omlin A, Gillessen S, APCCC 2024 expert panel. PMID: 41407614 [PubMed - as supplied by publisher]
	Re: European Study of Prostate Cancer Screening - 23-Year Follow-up. Eur Urol Nguyen DD, Kulkarni GS, Guyatt GH. PMID: 41407562 [PubMed - as supplied by publisher]
	Re: Niraparib and Abiraterone Acetate plus Prednisone for HRR-deficient Metastatic Castration-sensitive Prostate Cancer: A Randomized Phase 3 Trial. Eur Urol McKenzie J, Azad AA. PMID: 41407561 [PubMed - as supplied by publisher]
	Letter to the Editor: Capivasertib plus abiraterone in PTEN-deficient metastatic hormone sensitive prostate cancer: CAPItello-281 phase III study. Ann Oncol Turco F, Vogl UM, Lin HM, Pedrani M, Leone G, Gillessen S. PMID: 41407194 [PubMed - as supplied by publisher]
	Targeting the NR4A3-RNF139-ATF6 pathway as a therapeutic and diagnostic strategy in bladder cancer. Pathol Res Pract Cui H, Fan X. PMID: 41406921 [PubMed - as supplied by publisher]
	Association between kidney stones and future risk of kidney cancer: A systematic review and meta-analysis. Can Urol Assoc J Bhojani N, Miller LE, Bhattacharyya S, Chen KW, Kallidonis P, Contreras PS, Somani BK, Gauhar V, Chew BH. PMID: 41406348 [PubMed - as supplied by publisher]
	Lactate metabolism orchestrates immune dysregulation in renal cancer: A multi-omics and causal inference study. Sci Prog Li J, Liu C, Fu Z, He Q, Liu X, Sun Z. PMID: 41406083 [PubMed - indexed for MEDLINE]
	Multi-omics data integration for enhanced cancer subtyping via interactive multi-kernel learning. Brief Bioinform Cao H, Wang T, Xu Z, Zhao X, Liu G, Yang X, Fang R, Luo Y, Zeng P, Yu H, Zhang Y, Cui Y. PMID: 41405963 [PubMed - indexed for MEDLINE]
	From Radiomics to Radiogenomics: Decoding Renal Cell Carcinoma Biology for Precision Medicine-a narrative review. Insights Imaging He Z, Huang L. PMID: 41405787 [PubMed]

Articles 1 - 20 / 174643

Page 1 of 8733



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy